glp-1 gip zepbound Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with drugs among patients with type 2 diabetes, a large retrospective cohort As insurers struggle with GLP-1

Repeated injections in the same area can cause tissue damage or irritation, which can lead to severe complications such as skin infections and the development of lumps

PepZinGI a highly bioavailable source of zinc reduces dyspepsia, e.g., upper abdomen discomfort, gastritis, bloating, nausea and vomiting all common gastrointestinal side effects of Ozempic and other GLP-1 medications

Emotion Identification and Regulation: Many autistic individuals have alexithymia difficulty identifying and describing their own emotions

The latest update from the Judicial Panel on Multidistrict Litigation (JPML) indicates that there are currently seven Ozempic-related lawsuits grouped in the recently established Multidistrict Litigation (MDL)